Sharps Technology’s actions almost doubled on Monday after the manufacturer of medical devices announced a decision of $ 400 million to finance a new cash strategy built around Solana’s native token. The action jumped by 96%, from $ 7.40 to an intra -day summit of $ 14.53 before relaxing at $ 12.01 to this writing.
Sharp objects have signed a letter of intent with the Solana Foundation to buy Solana tokens (soil) via a private investment in the public equity transaction (PIP) – a type of financing agreement where accredited investors buy shares from a listed company to a discount on the current market price.
The agreement, which should be concluded on August 28, lock the objects of powers acquire $ 50 million in soil chips at a discount of 15% compared to their average price of 30 days.
Investors can finance their allowances using locked or unlocked soil, receiving preinforced and stapled mandates, a structure that links exposure to actions directly to Solana.
Retling objects also announced the appointment of the Jamo co -founder, Alice Zhang, as director of investments to lead the quarter of work and added James Zhang as a strategic advisor – two well -known figures from the Solana ecosystem.
In relation: Galaxy Digital, Multicoin, Jump Crypto Plan 1B $ Solana Fund: Report
Companies in the health sector rotate treasury bills
Cryptographic cash companies are listed companies that hold digital assets like Bitcoin (BTC) or soil on their balance sheet, which gives investors an indirect exposure to cryptographic assets via their shares. The idea was designed for the first time by Michael Saylor of the strategy in 2020 and has since inspired hundreds of companies to follow suit.
The model recently gained ground in the health sector, where several small capitalization and CAP companies have pivoted in treasury bills to diversify and attract the attention of investors.
In November 2024, Hoth Therapeutics, a New York-based biopharma developing therapies for the skin, cancer and autoimmune diseases, said that it would allocate $ 1 million dollars as a treasure motor, supervising movement as an inflation hedge.
https://www.youtube.com/watch?v=npzqd7tsqmg
In March, the trend reached Atai Life Sciences, a biopharma classified in Nasdaq developing psychedelic mental health treatments. The founder Christian Angermeryer said that the company would buy $ 5 million in Bitcoin, arguing in a subordinate position that drug development is “eager for liquidity” and that regulatory approvals can take more than a decade.
In July, 180 life sciences, a biotechnology working on anti-inflammatory therapies, renamed ethzilla and announced its intention to build an ether treasure of $ 425 million after its stock dropped by 99%.
Wall Street’s office Charles Schwab recently warned in an educational video that companies “putting big pieces of money in a historically volatile asset which is not linked to their core business has lifted one or two red flags.”
Review: Asia Express: “ China’s microstrategy ‘Meitu sells all its bitcoins and Ethereum